Patents
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
10/2002
10/09/2002CN1373666A Medicament with protective effect against oxidative-toxic substances, particularly against cardiotoxin substances
10/08/2002US6462201 Process for the production of N-vinyl-2-pyrrolidone by vinylation
10/08/2002US6462048 3-(2-(4-methylpiperazin-1-yl)-benzylidene)-1,3-dihydro-indol-2-one for example; useful as psychotherapeutic agents
10/08/2002CA2172354C Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them
10/03/2002WO2002076939A2 Cysteine protease inhibitors
10/03/2002WO2002076395A2 Agents and methods for treatment of cancer
10/03/2002WO2002076375A2 Process for the preparation of benazepril
10/03/2002US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
10/03/2002CA2442573A1 Process for the preparation of benazepril
10/03/2002CA2441394A1 Agents and methods for treatment of cancer
10/02/2002EP0679641B1 Sulfonamide and sulfonic ester derivatives each having tricyclic hetero ring
10/02/2002CN1371907A Process for oximation reaction cyclohexaone continuous feeding
10/02/2002CN1371906A Process of distilling residue liquid for recovering and reusing hexanolactam extractant
10/02/2002CN1371905A Process for synthesizing 'epsilon'-hexanolactam
10/02/2002CN1091763C Method for preventing hydroxylamine from decomposing in inorganic solution for prparing caprolactam by using hydroxylamine phosphate oximation method
10/01/2002US6458784 Vitronectin receptor antagonists
10/01/2002US6458770 Parenteral formulations comprising carbamazepine or its derivatives
09/2002
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
09/26/2002WO2002074750A1 Metalloproteinase inhibitors
09/26/2002WO2002074748A1 Metalloproteinase inhibitors
09/26/2002WO2002074746A1 Benzazepine derivatives
09/26/2002WO2002074735A2 Biurethane derivatives
09/26/2002US20020137738 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
09/26/2002US20020137737 1-(3-methyl-1-(1,3-dihydro-1-methyl-2-oxo-5-phenyl-2H-1,4 -benzodiazepin-3-ylcarbamoyl)-butyl)-cyclopent-3-enecarboxylic amide, for example; gamma-secretase inhibitors; Alzhemier's disease, Down's Syndrome
09/26/2002DE10113402A1 New N,N'-bis-(Aminocarbonyl)-hydrazine derivatives are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, apoplexy, restenosis or tumors
09/26/2002CA2441427A1 Biurethane derivatives
09/26/2002CA2440632A1 Metalloproteinase inhibitors
09/26/2002CA2440631A1 Metalloproteinase inhibitors
09/25/2002EP1242375A2 Method for purifying lactames
09/25/2002EP0923550B1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
09/25/2002CN1371374A Substituted heterocycle fused gamma-carbolines
09/24/2002US6455472 Herbicides, acaricides, nematicides and insecticides for crops
09/19/2002WO2002072555A1 Process for preparing certain substituted caprolactams
09/19/2002DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use
09/18/2002EP1240140A1 Method for the production of n-alkenyl amides
09/18/2002EP1240139A1 Method for producing n-alkenyl amides
09/18/2002EP0888436B2 Solid composition of heterocyclic compounds and/or oxime esters and inert porous carrier materials
09/18/2002EP0804427B1 Lta4 hydrolase inhibitors
09/18/2002CN1370176A Subsstituted heterocycle fused gamma-carbolines
09/18/2002CN1370169A Substituted heterocycle fused gamma-carbolines
09/17/2002US6451842 Cyclic amine derivatives and their use as drugs
09/17/2002US6451789 Central nervous system disorders; cognition activators
09/17/2002US6451753 Cyclic carbamate, lactonoxy or lactam structure and/or oxime esters and inert porous carrier of given surface area; storage stable solid, free-flowing form
09/12/2002WO2002070493A1 Bisaryl derivatives having fsh receptor modulatory activity
09/12/2002WO2002070474A1 Process for producing lactam
09/12/2002WO2002069895A2 Heterocyclic analgesic compounds and methods of use thereof
09/12/2002US20020128474 Process for preparing certain substituted caprolactams
09/12/2002US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
09/12/2002US20020128208 Such as 4-benzoylamino-(2-(2-hydroxyethyl)-piperazin-1-yl-methyl)-phenyl)-benzene -sulfonamide; for treatment of hypertension; treatment of kidney disorders
09/12/2002CA2434184A1 Bisaryl derivatives having fsh receptor modulatory activity
09/11/2002EP1238970A1 Cycloamine ccr5 receptor antagonists
09/10/2002US6448394 Formation of blocked isocyantes without free isocyanate present by reacting amine with carbonic acid derivative
09/10/2002US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors
09/05/2002US20020123486 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
09/03/2002US6444810 Acylmercaptoalkanoylamino lactam esters or acids are converted to the corresponding mercaptoalkanoylamino lactam ester or acid under basic conditions using an agent that minimizes amount of disulfides
08/2002
08/29/2002WO2002042273A3 Acid derivatives useful as serine protease inhibitors
08/29/2002WO2002037937A3 Acid derivatives useful as serine protease inhibitors
08/29/2002WO2002002520A3 Compounds to treat alzheimer's disease
08/29/2002WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
08/29/2002US20020120154 Method for preparing lactam
08/29/2002US20020119964 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
08/27/2002US6441231 Optically active quarternary ammonium salt with axial chirality, method for producing thereof, and application thereof for asymmetric synthesis of α-amino acid
08/22/2002WO2002064557A2 New crystal forms of oxcarbazepine and processes for their preparation
08/22/2002WO2002040471A3 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
08/22/2002US20020115657 Such as 3-(4-(2-(10,11-dihydro-dibenzo(b,f)azepin-5-yl)-ethoxy)-phenyl)-2 -ethoxypropionic acid; for treatment/ prevention of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
08/22/2002US20020115652 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
08/22/2002CA2437402A1 New crystal forms of oxcarbazepine and processes for their preparation
08/21/2002CN1365347A Anthracene derivatives and organic electroleuminescents device made by using the same
08/20/2002US6436923 Compounds and methods for modulation of estrogen receptors
08/20/2002CA2216129C Lactam-containing hydroxamic acids
08/15/2002WO2002062765A1 METHOD FOR PRODUCING N,N'-CARBONYLBIS-ε-CAPROLACTAM
08/15/2002WO2002042244A3 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
08/15/2002US20020111344 Antidiabetic agetns, dietetics
08/15/2002US20020111343 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-Amyloid peptide release and/or its synthesis by use of such compounds
08/14/2002EP1230220A1 Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis
08/14/2002EP1229913A1 Substituted 1-benzazepines and derivatives thereof
08/13/2002US6433166 Process for producing ε-caprolactam
08/13/2002US6433165 Chemokine receptor antagonists and methods of use therefor
08/08/2002WO2002060870A2 Delta agonist analgesics
08/08/2002WO2001093840A3 Ligands of integrin receptors
08/08/2002WO2001077068A3 Process for preparing 6-aminocaproamide
08/08/2002US20020107241 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease
08/08/2002US20020107239 Cyclized amide derivatives
08/08/2002US20020107235 Carbamate and hydroxy groups containing phenanthrene derivatives; useful to treat obesity, diabetes and inflammation
08/08/2002DE10105030A1 Verfahren zur Herstellung von N,N'-Carbonylbis-Epsilon-caprolactam A process for the preparation of N, N'-carbonylbis-epsilon-caprolactam
08/07/2002CN1362408A Hexanolactam hydrofining process with circulated catalyst
08/06/2002CA2231812C Cyclic nitrones and pharmaceutical compositions containing them
08/01/2002WO2002059074A1 Benzylamine analogue
08/01/2002WO2002022572A3 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
08/01/2002US20020103374 Spiro quarternary ammonium salt compounds, used as phase transfer catalyst for stereoselective alkylation
08/01/2002US20020103188 Peroxisome Proliferator-Activated Receptors (PPAR); diabetes and obesity; 3-(4-(2-(10,1-Dihydro-dibenzo(b,f)azepin-5-yl)ethoxy)-pheny)-2-ethoxy -propionic acid, for example
08/01/2002US20020103184 Cyclic malonamides as inhibitors of a beta protein production
08/01/2002CA2435883A1 Benzylamine analogue
07/2002
07/31/2002EP1226139A2 Cyclized amide derivatives for treating or preventing neuronal damage
07/31/2002EP1226122A1 Bicyclic vasopressin agonists
07/25/2002WO2002057236A1 Phenyl derivatives
07/25/2002WO2002040452A3 Production of alkyl 6-aminocaproate
07/25/2002US20020099084 Pharmaceutically active compounds and methods of use
07/25/2002DE10102322A1 New disubstituted and trisubstituted benzene derivatives useful as coagulation inhibitors for the treatment of thromboembolic diseases
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 88